MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose SM vs. Medical
Karl Miller1, R Turró2, J W Greve3
1Bariatric Medical Unit, Wehrle Diakonissen Private Clinic, Salzburg, Austria. karl@miller.co.at.
Obesity Surgery
|July 30, 2016
Summary
Endolumenal Pose(SM) therapy resulted in significantly greater weight loss and improved satiety compared to conventional diet and exercise for obesity treatment. This endoscopic intervention offers a safe and effective option for patients seeking substantial weight reduction.
Area of Science:
- Bariatric Endoscopy
- Obesity Management
- Gastrointestinal Surgery
Background:
- Pose(SM) is an endoscopic weight-loss intervention using gastric fundus and distal body suture anchors.
- Previous observational studies indicate Pose(SM) is safe and effective for weight loss.
- This study reports 12-month outcomes from a randomized controlled trial comparing Pose(SM) to conventional medical therapy.
Purpose of the Study:
- To compare the efficacy of Pose(SM) versus diet/exercise alone for weight loss in obese subjects.
- To assess changes in satiety parameters following Pose(SM) intervention.
- To evaluate the safety of the Pose(SM) procedure.
Main Methods:
- Randomized controlled trial with a 3:1 allocation to Pose(SM) or control (diet/exercise).
- Subjects with Class I-II obesity were included.
- Total body weight loss (%TBWL) and excess weight loss (%EWL) were measured at 6 and 12 months; satiety was also assessed.
Main Results:
- Pose(SM) group achieved 13.0% TBWL (45.0% EWL) versus 5.3% TBWL (18.1% EWL) in controls at 12 months (p < 0.01).
- Pose(SM) significantly improved satiety parameters (p < 0.001) at 6 and 12 months.
- No serious adverse events related to the device or procedure were reported.
Conclusions:
- Pose(SM) treatment led to significantly greater weight loss than diet/exercise alone at 12 months.
- The endoscopic intervention also demonstrated significant improvements in satiety.
- Pose(SM) represents a safe and effective endoscopic bariatric therapy.


